All In MedTech

Device Trial Radar · NCT02612519

Alfapump System Versus Transjugular Intrahepatic Portosystemic Shunt and Paracentesis in the Treatment of Ascites

Alfapump System Versus Transjugular Intrahepatic Portosystemic Shunt and Paracentesis in the Treatment of Ascites. A Multicentre Randomised Controlled Study

Last checked: Nov 19, 2026Latest source record: Jul 31, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

15

Actual

Start

Nov 2015

Primary completion

Apr 30, 2019

Study completion Apr 30, 2019

Sponsor

Lead sponsor
University of LeipzigAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 23, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Multicentre, open, randomised, and controlled trial conducted in patients diagnosed with recurrent/refractory ascites who meet inclusion/exclusion criteria. The efficacy of the Alfapump, TIPS and paracentesis with regard to the treatment of ascites will be compared. All patients will receive medical care for cirrhosis and ascites according to the institution's standards of care. Standard of care may include, but is not limited to the administration of diuretics, paracentesis and consideration for orthotopic liver transplantation.

Conditions

  • Liver Cirrhosis

Interventions

  • AlfapumpDevice

    Implantation of Alfapump

  • TIPSDevice

    Implantation of TIPS

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary outcome is the (average) number of paracenteses per quarter during time without device abandonment, transplant, or death documented on a time horizon of 4 quarters (i.e.1 year).Time frame: Starts with randomisation and ends after 12 months or when a device abandonment, transplant, or death occurs before.

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Medizische Klinik III

    Aachen, Germany

  • Medizinische Klinik und Poliklinik 1 - Gastroenterologie

    Dresden, Germany

  • Uniklinik Leipzig

    Leipzig, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.